Despite the developm ent ofsophisticated diagno stic procedures and treatmentsf or otherotologic and neurotologic conditions, tinnitus remains difficult to manage. Several investigators have shown that lidocaine has an effec t on temporarily (for severa l minutes) relieving subjective tinnitus, but f ew reports have described the response to lidocaine according to different individual patient characteristics. Over a 24-yearperiod, we administered either 60 or 100 mg ofintravenous lidocaine to 117 ears in 103 patients with subjective tinnitus (14 patients receive d treatment bilaterally). Within 5 minutes oftreatment, 83 ears (70.9%) experienced either complete or partial relief The lOO-mg dose was more effective than the 60-mg dose in completely eliminating tinnitus (34.9 vs 20.6%), but the two doses were comparable when elimination rates were combined with rates of reduction of tinnitus (71.1 and 70.6%, respectively) . With respect to individual pati ent characteristics, ears with low-to middle-tone tinnitus had a better response, as did ears in which the hearing level was 40 dB or higher and ears of pati ents aged 60 years and older. The response to lidocain e was not correlated with the baseline loudness of tinnitus or to its duration.
Introduction
Despite the development of sophisticated diagnostic procedures and treatments for other otologic diseases, tinnitus rem ains difficult to manage. The suppress ive effec t of local anesthetics on tinnitus was discovered serendipitously by Barany in 1935 .\ He reported that tinnitus stopped when procaine was administer ed into the inferior turbinate as a local anesthetic during intranasal surgery. Thi s clini cal ob servation prompted Lewy to perform the first stud y of the use of local anesthetics for relief of tinnitus. 2 From the Departmen t of Otolaryngology, Tokyo Medical Uni versity (Dr. Otsuka and Dr. Suzuki While investigators have shown that lidocaine has an effect on subjective tinnitu s, few have described the response according to different individu al patient characteristics. In this articl e, we describe the response to IV lidoc aine according to variou s individual parameters.
Patients and methods
Between 1977 and 200 I, we admini stered IV lidocaine to 117 ears in 103 patient s with subje ctive tinnitu s at the Pulec Ear Clinic in Los Angeles; 14 pati ent s were treated bilaterall y. This group includ ed patient s aged 23 to 83 yea rs (mean: 55). All patients pro vided a thorough history, including information on the durati on, location , seve rity, and nature of the tinnitu s as well as inform ation on smoking, caffeine intake, head injury, noise expo sure, serio us illness, and ototoxic drug expos ure . The physical and neuro tologic exa minations included audiometry for pure tone s and speech discr imin ation, ea rly latency brainstem audiometry, electron ystagmograph y, and petrous pyramid x-rays . Magnetic resonance imaging was performed on patient s who were suspec ted of having an acoustic neuroma. Blood tests included measurements of the complete blood count, electrolyte levels, thyro id and liver function , fluore scent treponem al antibody levels, lipoprotein phenotypes, and 5-hour glu cose tolerance .10.1I Audiometric evaluation was also performed to determ ine the loudness and pitch of tinn itus. The cau ses of tinnitus were varied (table I) . Response and pitch. Sixty of the 117 ears were tested to assess the pitch of tinnitu s. Ears in which the pitch was less than 4,00 0 Hz (low-to middle-tone tinnitus) had a better response than did those with a higher pitch ( figure  3 ). In the former gro up, tinnitus was eliminated in 8 of2 1 ears (38.1%) and reduced in 10 othe rs (47 .6%)-an overall improvement rate of 85.7% ( 18121). In the latter group (high-freq uency tinnitus), tinnitus was elimi nated in 9 of 39 ears (23.1%) and reduced in 16 others (41.0%)-an overall improvement rate of 64. 1% (25/39) .
Response and hearing level. Hearing level was assessed in 11 6 of the 117 ears . Ears with a hearing level of 40 dB or more had a significantly better response (p = 0.0067) than did those with a lower level (figure 4) . Hearing level was less than 40 dB in 85 ears; tinnitus was eliminated in 26 (30.6%) and reduced in 29 (34.1%)-an overall improvement rate of 64.7 % (55/85 ). Among the 3 1 ears in which the hearing level was more than 40 dB, With the patient in a sitting position, either 60 or 100 mg (3 or 5 ml) of 2% lidocaine was injecte d intravenously.
The smaller dose was administered to those ears that were treated between 1977 and 1984 (n = 34) and the larger dose to those that were treated thereafter (n =83). We asked eac h patient to evaluate any perceived altera tion in tinnitus durin g the first 5 minute s after injection , including an estimate of the percenta ge of reduction in those patients who reported a reduction . Post-treatment tinnitu s status was classified as either absent, reduced, no change , or worse. An estimated reduction of less than 20% was considered to represe nt no change. Chron ic otit is media 1 (0.9)
Results
Overall respon se. Following treatment of the group as a whole, tinnitu s was absent in 36 ears (30.8 %), reduced in 47 ears (40.2 %), unchanged in 26 ears (22.2%), and worse in 8 ears (6.8%) (figure I). Lidocaine was either completely or partially effec tive in 83 ears (70.9%). Alth ough IV lidocaine provides only temporary (for several minutes) relief in most cases , two of our patients experienced lasting (for several months) relief. Respon se and etiology. We calculated the rate of response in ears with the four most common etiologies (table 2). The best response was seen in those with presbycusis Table 2 . Rates of response in ears with the most common etiologies (84.2%) and the worst in those with acoustic traum a (55.6%).
Response and dose. The 100-Etio logy mg dose of lidocaine was more effec tive than the 60-mg dose in Presbycus is (n = 38) tinnitus was eliminated in 10 (32.3%) and reduced in 18 (58.1%)-an overa ll improvement rate of90.3% (28/31) . Response and age. Response was significantly better (p = 0.026) in patients who were 60 years or older ( figure  5 ). In patients who were younger than 60 years , tinnitus was eli minated in 18 of7 1ears (25.4%) and reduced in 27 (38.0%)-an overa ll improvement rate of 63.4% (45/7 1). Among the patients who were 60 years or older , tinnitus was eliminated in 18 of 46 ears (39. 1%) and reduced in 20 (43.5%)-an overa ll improve ment rate of 82.6% (38/46) .
Other parameters. We also analyzed respo nses according to the degree of pretreatment loudnes s of tinnitus and the duration of the tinnitus and found no corre lation .
Discussion
The finding that local anes thetics, particularly lidocaine, can relieve tinnitus supports the hypothesis that tinnitu s might be caused by neural hyperactivity. It is known that increase d sodium conductance increases the sensitivity of axons and in many cases makes the mechanoreceptors sensitive . Lidocaine is a sodium channel blocker, and decreased sodium conduction affec ts neurons that have high discharge rates. Several authors"? have reported that lidocaine was effective in relieving tinnitus in 60 to 80% of patients, and our results were comp atible with these findings.
In our series, 100 mg of IV lidocaine was more effec tive than 60 mg. Perucca and Jackson reported that a lidocaine plasma concentration of at least 1.0 ug/ml is necessary to reduce tinnitus." However, higher leve ls are associated with more pronounced side effects. We observe d no case of significa nt side effec ts with either the 60-or 100-mg dose.
Our study showed that lidocaine was more effective in alleviating low-to middle-tone tinnitu s than high-tone tinn itus. Several other studies yielded similar results .P:" Shea reported that IV lidocaine blocks 10% of the transmission of neural hyperactivity throu gh each synapse, and thus it has mor e effect on the slow path way (low-frequency tinnitu s) than on the rapid pathway (high-frequency tinnitu s). "
In recent years, increased efforts have been made to find a more easily admini stered pharmaceuti cal treatment for tinnitu s that is as effective as IV lidocaine; administration oflidocaine is not a routine treatment option because of its inconvenience. Seve ral investigators have shown that the re sponse to lidoc aine can predict the response to carbamazepin e and serotonin, and therefore these other agents can be used in the selection of suitable candidates for treatment. 7.15.16 
